These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 17458507)

  • 21. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
    Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
    Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laminin-binding integrins in tumor progression and metastasis.
    Ziober BL; Lin CS; Kramer RH
    Semin Cancer Biol; 1996 Jun; 7(3):119-28. PubMed ID: 8773297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypoxia and angiogenesis].
    Simon JM
    Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical determinants of metastasis.
    Fidler IJ
    Semin Cancer Biol; 2002 Apr; 12(2):89-96. PubMed ID: 12027580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic.
    Epstein RJ
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):443-52. PubMed ID: 17786538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.
    Willhauck MJ; Mirancea N; Vosseler S; Pavesio A; Boukamp P; Mueller MM; Fusenig NE; Stark HJ
    Carcinogenesis; 2007 Mar; 28(3):595-610. PubMed ID: 17056607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow.
    Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK
    Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.
    Xu Q; Wang S; Jiang X; Zhao Y; Gao M; Zhang Y; Wang X; Tano K; Kanehara M; Zhang W; Ishida T
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):624-31. PubMed ID: 17581219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
    Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
    J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological consequences of tumor hypoxia.
    Höckel M; Vaupel P
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):36-41. PubMed ID: 11395851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-extravasation model -- selection of highly motile and metastatic cancer cells.
    Brandt B; Heyder C; Gloria-Maercker E; Hatzmann W; Rötger A; Kemming D; Zänker KS; Entschladen F; Dittmar T
    Semin Cancer Biol; 2005 Oct; 15(5):387-95. PubMed ID: 16054390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in molecular mechanisms of tumor metastasis and angiogenesis.
    Harlozinska A
    Anticancer Res; 2005; 25(5):3327-33. PubMed ID: 16101146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axis of evil: molecular mechanisms of cancer metastasis.
    Bogenrieder T; Herlyn M
    Oncogene; 2003 Sep; 22(42):6524-36. PubMed ID: 14528277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.